youtube_live
Q3 2026 pajamos • po 3 d.
Žr. išsamią informacijąchevron_right
AMGN34:BVMF
Amgen Inc. BDR
91,17 BRL
0,00%
(0,00) 1 D.
10-30, 16:56:00 GMT−3 · BRL
search
Visi simboliai
| Simbolis | Kaina | Keisti | Pokytis, % |
|---|
insights_autoGeneruojamos svarbiausios „AMGN34“ įžvalgos...
Atidaryti
90,55 BRL
Aukšta
91,74 BRL
Žema
90,55 BRL
Rinkos kapitalizacija
251,94 mlrd.
Vid. kiekis
427,00
Apimtis
252,00
52 sav. aukšta
91,74 BRL
52 sav. žema
47,76 BRL
Neapmokėtos akcijos
540,63 mln.
Darbuotojų skaičius
32 tūkst.
Atidaryti
90,55 BRL
Aukšta
91,74 BRL
Žema
90,55 BRL
Rinkos kapitalizacija
251,94 mlrd.
Vid. kiekis
427,00
Apimtis
252,00
52 sav. aukšta
91,74 BRL
52 sav. žema
47,76 BRL
Neapmokėtos akcijos
540,63 mln.
Darbuotojų skaičius
32 tūkst.
Naujienų istorijos
Iš žiniatinklio šaltinių ir naujienų partnerių
Seeking Alpha
·
prieš 22 valandas
Amgen: I Have Clear Doubts About This Company Headed Into Earnings - Earnings Preview
Yahoo Finance
·
prieš 1 dieną
Amgen (AMGN) Increases Despite Market Slip: Here's What You Need to Know
MarketWatch
·
prieš 1 dieną
Amgen Inc. stock outperforms competitors on strong trading day
Yahoo Finance
·
prieš 2 dienas
Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Profilis
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Apie „Amgen Inc. BDR“
Generalinis direktoriusRobert A. Bradway
Darbuotojai31,5 tūkst.
Įkurta1980
Pagrindinė būstinėTausand Ouksas, Kalifornija, Jungtinės Valstijos
Sektorius-
Svetainėamgen.com